Tessera Defense & Homeland Security Inc. has filed a Form 8-K with the Securities and Exchange Commission (SEC) detailing the issuance of over 6.5 million shares of common stock. The filing, dated October 19, 2026, is significant as it provides insights into the company's capital structure and financial maneuvers.

Background on Tessera Defense

Tessera Defense & Homeland Security Inc. is a Delaware-based company focused on providing defense and security solutions. The company operates in the prepackaged software sector and has undergone several name changes in recent years, previously known as BiomX Inc. and Chardan Healthcare Acquisition Corp.

The Form 8-K is a current report that companies must file with the SEC to disclose major events that shareholders should know about. This form is used to inform investors about significant changes or developments that could affect the company's financial position.

Details from the Filing

According to the filing (Accession Number: 0001213900-26-110754), between October 13, 2026, and October 19, 2026, Tessera issued 6,529,494 restricted shares of common stock to Mandragola Ltd. These shares were issued in four tranches following cashless exercises of a five-year warrant issued to Mandragola on April 13, 2026. This warrant was part of Tessera's acquisition of a 60% interest in Dr. Frucht Systems Ltd. (DFSL).

The filing states, "The DFSL Warrant is exercisable on a cashless basis for such number of shares of common stock equal to the Black-Scholes value of a Warrant Share." It also notes that the warrant cannot be exercised if Mandragola, along with its affiliates, would own more than 9.99% of the company's outstanding common stock after the exercise.

Additionally, the Warrant Shares were issued under the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, meaning they are considered restricted securities under Rule 144.

As of October 19, 2026, following the issuance of these shares, Tessera had a total of 20,663,177 shares of common stock outstanding.

Impact of the Filing

This filing may affect various stakeholders, including shareholders and potential investors. The issuance of new shares can dilute the ownership percentage of existing shareholders, which is an important consideration for those holding stock in the company. Investors may also be interested in how this stock issuance aligns with Tessera's strategic goals and financial health.

What's Next?

The filing does not say what happens next. However, it is common for companies to continue to provide updates on their financial health and strategic initiatives in future filings. Investors and analysts will likely be watching Tessera's subsequent reports to gauge the impact of this stock issuance on the company's performance.